scholarly article | Q13442814 |
P2093 | author name string | Jing Li | |
Junfeng Zhang | |||
Xi Chen | |||
Yu Zhou | |||
Yuchen Liu | |||
Chen-Yu Zhang | |||
Ling Jin | |||
Ke Zen | |||
Xiaohong Jiang | |||
Yujing Zhang | |||
Dameng Li | |||
Dongxia Hou | |||
Geyu Zhou | |||
Zhengya Liu | |||
Xihan Li | |||
Yuda Chen | |||
Danping Chu | |||
Chenfei Tian | |||
Waner Jiang | |||
Zhanzhao Yang | |||
P2860 | cites work | Exosomes: composition, biogenesis and function | Q29547721 |
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes | Q29617554 | ||
Shedding microvesicles: artefacts no more | Q29619416 | ||
The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses | Q33679584 | ||
Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth | Q34289902 | ||
Argonaute 2 complexes selectively protect the circulating microRNAs in cell-secreted microvesicles | Q34450493 | ||
Pharmacotherapy of addictions | Q34810395 | ||
Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. | Q36280594 | ||
Transforming growth factor-beta and the immune response: implications for anticancer therapy | Q36944384 | ||
Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution | Q37036373 | ||
Microvesicle-mediated transfer of microRNA-150 from monocytes to endothelial cells promotes angiogenesis | Q37629798 | ||
Microvesicle-mediated delivery of transforming growth factor β1 siRNA for the suppression of tumor growth in mice | Q39021321 | ||
Exosomes are natural carriers of exogenous siRNA to human cells in vitro | Q39061886 | ||
Microvesicle-delivery miR-150 promotes tumorigenesis by up-regulating VEGF, and the neutralization of miR-150 attenuate tumor development | Q39065988 | ||
Exosomes: a new delivery system for tumor antigens in cancer immunotherapy. | Q40478979 | ||
Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene | Q41157124 | ||
Drug addictions: towards socially accepted and medically treatable diseases | Q44123892 | ||
Effective detection and quantification of dietetically absorbed plant microRNAs in human plasma. | Q53307776 | ||
SiRNA delivery with exosome nanoparticles. | Q53423662 | ||
Secreted monocytic miR-150 enhances targeted endothelial cell migration | Q84525686 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | morphine | Q81225 |
opioid | Q427523 | ||
P304 | page(s) | 17543 | |
P577 | publication date | 2015-12-03 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse | |
P478 | volume | 5 |
Q38743388 | Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading |
Q40148221 | Asn194Lys mutation in RVG29 peptide increases GFP transgene delivery by endocytosis to neuroblastoma and astrocyte cells |
Q43808328 | Bioinspired Cell-Derived Nanovesicles versus Exosomes as Drug Delivery Systems: a Cost-Effective Alternative. |
Q48418503 | Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer |
Q64238147 | Design strategies and application progress of therapeutic exosomes |
Q38737886 | Development and regulation of exosome-based therapy products |
Q47315020 | Epigenetic regulation of motivated behaviors by histone deacetylase inhibitors |
Q92776477 | Exosomal DNA Aptamer Targeting α-Synuclein Aggregates Reduced Neuropathological Deficits in a Mouse Parkinson's Disease Model |
Q89909722 | Exosome-based small RNA delivery: Progress and prospects |
Q26747740 | Exosome-mediated small RNA delivery for gene therapy |
Q58608410 | Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery |
Q39281941 | Exosomes and the Prion Protein: More than One Truth |
Q39301571 | Exosomes and their Application in Biomedical Field: Difficulties and Advantages. |
Q39396904 | Exosomes as Reconfigurable Therapeutic Systems. |
Q57464992 | Exosomes in perspective: a potential surrogate for stem cell therapy |
Q38795614 | Exosomes in stroke pathogenesis and therapy |
Q49503021 | Exosomes serve as nanoparticles to suppress tumor growth and angiogenesis in gastric cancer by delivering hepatocyte growth factor siRNA. |
Q37614565 | Exosomes, an Unmasked Culprit in Neurodegenerative Diseases. |
Q39395324 | Exosomes: promising sacks for treating ischemic heart disease? |
Q64249165 | Extracellular Vesicles: Delivery Vehicles of Myokines |
Q94671460 | Extracellular vesicle-mediated transfer of miR-21-5p from mesenchymal stromal cells to neurons alleviates early brain injury to improve cognitive function via the PTEN/Akt pathway after subarachnoid hemorrhage |
Q52726716 | Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery. |
Q39111448 | Extracellular vesicles for nucleic acid delivery: progress and prospects for safe RNA-based gene therapy |
Q48095278 | Focus on Mesenchymal Stem Cell-Derived Exosomes: Opportunities and Challenges in Cell-Free Therapy. |
Q100512500 | Gene therapy and gene correction: targets, progress, and challenges for treating human diseases |
Q28554266 | Identification and Characterization of 293T Cell-Derived Exosomes by Profiling the Protein, mRNA and MicroRNA Components |
Q64277537 | Localized injection of miRNA-21-enriched extracellular vesicles effectively restores cardiac function after myocardial infarction |
Q47824357 | Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain. |
Q48618115 | Neuron-Targeted Nanoparticle for siRNA Delivery to Traumatic Brain Injuries |
Q33619374 | New Insight into Inter-kingdom Communication: Horizontal Transfer of Mobile Small RNAs |
Q39173469 | Pharmacokinetics of Exosomes-An Important Factor for Elucidating the Biological Roles of Exosomes and for the Development of Exosome-Based Therapeutics. |
Q48179184 | Potential Role of Extracellular Vesicles in the Pathophysiology of Drug Addiction |
Q26861645 | Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche |
Q64057113 | RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer's disease |
Q57458410 | Recent advancements in the use of exosomes as drug delivery systems |
Q45872562 | Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers. |
Q90377916 | Reprogramming extracellular vesicles with engineered proteins |
Q90000268 | Systemic Exosomal Delivery of shRNA Minicircles Prevents Parkinsonian Pathology |
Q58746877 | Targeted cancer therapy using engineered exosome as a natural drug delivery vehicle |
Q64977089 | The Phenotypic Effects of Exosomes Secreted from Distinct Cellular Sources: a Comparative Study Based on miRNA Composition. |
Q37210936 | The delivery of therapeutic oligonucleotides |
Q64109767 | The emerging role of exosomes in mental disorders |
Q97066865 | Therapeutic Effects of Transplanted Exosomes Containing miR-29b to a Rat Model of Alzheimer's Disease |
Q28075450 | Towards Therapeutic Delivery of Extracellular Vesicles: Strategies for In Vivo Tracking and Biodistribution Analysis |
Q91773846 | Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.